Centromere 17 copy number alteration: negative prognostic factor in invasive breast cancer?
about
HER2 in situ hybridization in breast cancer: clinical implications of polysomy 17 and genetic heterogeneityPrognostic significance of equivocal human epidermal growth factor receptor 2 results and clinical utility of alternative chromosome 17 genes in patients with invasive breast cancer: A cohort study.Impact of the 2013 ASCO/CAP HER2 revised guidelines on HER2 results in breast core biopsies with invasive breast carcinoma: a retrospective study.Relationship between gene status and selected potential biological features related to trastuzumab resistance and its influence on survival of breast cancer patients undergoing trastuzumab adjuvant treatment
P2860
Centromere 17 copy number alteration: negative prognostic factor in invasive breast cancer?
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Centromere 17 copy number alte ...... tor in invasive breast cancer?
@en
Centromere 17 copy number alte ...... tor in invasive breast cancer?
@nl
type
label
Centromere 17 copy number alte ...... tor in invasive breast cancer?
@en
Centromere 17 copy number alte ...... tor in invasive breast cancer?
@nl
prefLabel
Centromere 17 copy number alte ...... tor in invasive breast cancer?
@en
Centromere 17 copy number alte ...... tor in invasive breast cancer?
@nl
P2093
P1476
Centromere 17 copy number alte ...... tor in invasive breast cancer?
@en
P2093
Carmela Quero
Eliseo Mattioli
Francesco Giotta
Giovanni Simone
Maria Angela Caponio
Stella Petroni
Teresa Addati
Vincenza Rubini
P304
P356
10.5858/ARPA.2011-0327-OA
P577
2012-09-01T00:00:00Z